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Abstract
As the demands for the conduct of clinical trials rise, it becomes increasingly important to
establish a quantitative means of estimating the appropriate staffing resource to coordinate trial
related activities. There has been a limited amount of research conducted to evaluate methods or
tools to measure workload in the clinical trial setting. A literature search revealed a gap in the
literature about tools used to measure workload and its impact on clinical trial performance and
job satisfaction. The aim of this pilot project was to test the Ontario Protocol Assessment Level
(OPAL) complexity rating tool in generating quantitative measurements of workload for the
purpose of assessing operational efficiencies and identifying opportunities for process
improvement changes. The pilot project was conducted in a clinical trials unit consisting of
clinical research nurses (CRN), clinical research coordinators (CRC) and research managers who
participated in the project implementation. Concepts from the Institute for Healthcare
Improvement (IHI) Model for Improvement and Plan-Do-Study-Act (PDSA) were used to guide
project implementation and Lean principles for the interpretation of data findings. The findings
from the data showed that OPAL can be used as a quantitative means to measure workload, and
to assess factors affecting operational efficiencies.
Keywords: workload, workload measurement, clinical trials, clinical research
coordinator, clinical research nurse, skill-mix
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A Measure to Determine Acceptable Workload for Increasing Operational Efficiencies for
the Conduct of Clinical Trials
According to Casner and Gore (2010), “[h]umans who are overburdened with work tend
to hurry their performance, commit more errors, yield poor accuracy, become frustrated,
uncomfortable, and fatigued, and have poor awareness of their surroundings”…“[i]nterestingly,
humans who are underworked can exhibit many of the same symptoms” (p. 1). Therefore, a
balanced distribution of work would likely lead to greater productivity and efficiency. They
emphasized the need for a device to measure workload that “would allow us to approach any
work situation and acquire a numerical (or at least ordinal) measure of the level of workload
being experienced by a human operator” (Casner & Gore, 2010, p. 1). In parallel, they stated the
need to define “practical and sensible limits for workload”, emphasizing that in order to make
scientific inferences about numerical measurements of workload levels that these terms need to
be more rigorously defined (Casner & Gore, 2010, p. 1).
According to Milani et al. (2017) “few resources are available to quantify clinical trialassociated workload, needed to guide staffing and budgetary planning” (p. 1). They further
stated, that “the total number and frequency of procedures specified in each clinical trial
protocol…is increasing annually” and affecting the workload of clinical research personnel
required to perform these activities (Milani et al., 2017, p. 1). The lack of a method for
measuring the needs of patients participating in clinical trials hinders the ability of managers in
making precise staffing and budget projections and resource allocation decisions (Brennan et al.,
2019). Additionally, Brennan et al. (2019) indicated that when aspects of workload that affect
workflow and efficiency are not measured, these have the potential in impacting quality of care,
patient safety, and the integrity of research outcomes. This pilot project was implemented in a
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clinical trials unit to test and evaluate a workload measurement instrument for generating
workload related metrics that could be used to assess factors that impact staff performance and
job satisfaction and identify opportunities for process improvement changes to enhance overall
clinical trial performance.
Clinical Research Problem
The basis for this pilot project was the recurring need for research managers of a clinical
trials unit to accurately predict staffing requirements and assess work capacity of clinical
research staff. As a result, the research staff can more efficiently coordinate complex phase I
cancer trials for novel high-risk cell-based therapies (i.e., genetically modified CAR T cells) used
to treat a variety of cancer types – hematologic and solid tumor malignancies. This notion
provides a more precise estimation of the work capacity of research staff that facilitates a more
balanced distribution of work, resulting in greater staff productivity, efficiency and effectiveness,
better overall clinical trial performance, and a reduction in work-related stress. Additionally,
workload measurements could inform more efficient and cost-effective utilization of staff in
accomplishing clinical trial deliverables and meeting project timelines. Historically, research
managers from this clinical trials unit have relied primarily on their intuition and experience in
assessing feasibility for trial activation and estimating staff capacity for allocation of work
assignments. Feasibility assessments are largely based on the projected trial participant sample
size and intensity of study visit requirements. An accurate estimation of staffing requirements
ensures a safer conduct of clinical trials, high-quality study outcomes, enhances staff efficiency
and productivity, and reduces work-related stress and operational costs. For many cancer patients
with late stage or advanced disease, participation in clinical trials provide them access to
alternative investigational therapies in addition to routine care cancer therapies or in place of
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standard of care modalities that are no longer effective in preventing the progression of their
disease or resulting in durable remission of their cancer. Administration of investigational
therapies can provide benefits in slowing down disease progression, extending quality of life or
in some cases resulting in complete remission of cancer.
According to Malik and Lu (2019), “[p]hase I protocols are known to be the most
complex and burdensome to conduct” citing that “[c]ontemporary therapies in cancer phase I
trials are subject to newer endpoints with an effort to demonstrate a response signal or at least
evidence of target inhibition” (p. 519). They evaluated a total of 102 phase I protocols that were
active in 1996, 2006 and 2016 and found that there were significantly higher numbers of trial
procedures in the protocols from 2016 compared with 2006 and 1996 (P<0.001); 90% of these
trials were testing immune or targeted therapies (Malik & Lu, 2019). Drug development in
oncology continues to grow as the standard treatment for many cancers rapidly evolves to
include novel targeted therapies, immunotherapies, antibody-drug conjugates and chimeric
antigen T cell receptors (CARs) (Malik & Lu, 2019). The Food and Drug Administration is
granting breakthrough designations and conditional approvals based on phase I and II clinical
trial data, and as such the development process “should be rapid, efficient and able to implement
modern drug development models for upcoming novel drugs” (Malik & Lu, 2019, p. 519).
However, “[a]n efficient and successful phase I research program can be challenging in light of
an increase protocol complexity, restrictive inclusion and exclusion criteria, high personnel
workload, stringent regulatory criteria and a restrictive budget to manage the work” (Malik &
Lu, 2019, p. 519).
It is important to quantify workload because the design of phase I trials have substantially
increased study requirements making them more complex over the last 20 years (Malik & Lu,
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2019). In a study conducted to measure protocol design trends by the Tufts Center for the Study
of Drug Development (CSDD), they observed that the number of unique procedures had
increased at the annual rate of 6.5% and the frequency of procedures per protocol by 8.7% (Getz
et al., 2008). In the same study, they found that “investigative site work burden to administer
each protocol increased at an even faster rate of 10.5%” (Getz et al., 2008, p. 450). They
described how these protocol changes over time have had an impact on clinical trial performance
but have not been sufficiently quantified (Getz et al., 2008). According to Milani et al. (2017),
“[t]he assessment of the correct balance between size of workforce and number of trials is
therefore essential to ensure on the one hand patient safety and on the other data quality” (p. 7).
Project Purpose
The purpose of the pilot project was to evaluate the use of a quantitative measurement
tool for assessing clinical trial workload, and to identify opportunities for process change and
improvement, while promoting job satisfaction.
Project AIMS
1. Utilize OPAL to assess workload of research personnel involved in clinical trial
implementation
2. Use data from OPAL to evaluate operational efficiencies impacting clinical trial
performance
3. Identify other factors affecting staff efficiency and job satisfaction
4. Use project findings to inform about quality improvement strategies and enhancing job
satisfaction
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Project Objectives
1. Use PDSA cycle to test and study OPAL as a method for measuring clinical trial
complexity and workload
2. Use PDSA cycle to assess three factors from OPAL measurements that increase staff
effort and impact operational efficiency
3. Use PDSA cycle to
•

Identify and evaluate three dimensions from a job stress survey that impact staff
efficiency and contribute to job stress

•

Assess other factors identified from a review of protocol deviations reported for
four of the ten protocols in our project sample that may affect staff efficiency and
job stress

4. Use Lean principles to interpret project findings and make recommendations for process
improvement changes and goals, and improving job satisfaction
Review of the Literature
A literature search was conducted using PubMed, CINAHL, Google Scholar, Google and
Bing. The initial search used terms such as staffing ratio, staffing models, clinical research nurse,
clinical trial and caseload. Emulating the concept of the nurse-to-patient ratio, the search focused
on methods to determine a balanced distribution of trial protocols assigned to research personnel.
The early search generated studies conducted in more traditional and acute patient care settings,
such as the intensive care, pediatrics and medical-surgical units. These studies evaluated methods
for quantifying nurse staffing requirements based on ratio of patients to nurse or nursing hours
per patient day. Additionally, some studies suggested consideration of skill-mix utilizing
unlicensed assistive personnel to perform duties or tasks not requiring the completion by a
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registered nurse. Although the methods and findings from these studies could not be directly
correlated to the circumstances that were specific to the clinical trial setting, the concept of
balanced work distribution and skill-level mix was relevant.
Search terms were later refined to include workload, workload measurement, staffing
model, staffing ratio, skill-mix and clinical trials. Studies assessing workload and evaluating
workload measurement tools specific to the clinical trial setting were identified through a
snowball search. A total of six level II and level III good and high-quality studies were identified
and determined to be directly related to the project topic and adequately supported the aims for
this pilot project. However, it is notable that a gap in the literature for studies evaluating
workload measurement tools and the impacts that workload has on clinical trial performance still
exist.
A thorough review and appraisal of the literature that directly supported the aims of this
pilot project were performed. A summary of the synthesis and appraisal of the literature is
provided in Appendix A. The appraisal of the level and quality of the literature was performed
according to the criteria described in Johns Hopkins Nursing Evidence-Based Practice: Models
and Guidelines (Dang & Dearholt, 2018).
Synthesis of the Literature
Due to the unique methods described in each study for the measurement of workload, it
was important to include a summary of each tool or instrument described to provide better
context for the literature synthesis.
In a study conducted by Smuck et al. (2011), they tested the Ontario Protocol Assessment
Level (OPAL) complexity rating tool to measure trial complexity, case and total workload. Their
study was aligned with the Ontario Institute for Cancer Research’s mission for “process of
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improvements necessary to promote speed, quality, and accessibility of clinical trials for patients
in Ontario” and to assist clinical research professionals in working together to navigate through
the very complicated demands for conducting clinical research (Smuck et al., p. 80). OPAL
measured trial complexity and assigned a complexity level score based on criteria listed on a
pyramid scale. A working group of experienced clinical trial managers was assembled to develop
the standard rating scale for their tool to measure trial complexity that would later be applied to
measuring workload. The guiding principles for their tool were its ease of use, specificity to
measure work directly related to clinical trial professionals, usefulness in calculating workload
capacity for different phase trials but not be intended for academic review. The tool is based on a
pyramid scale that rates the complexity level of trial protocols from the least to the most
complex. They conducted the pilot testing for this tool across several of Ontario’s clinical trials
sites with the aim of demonstrating that “OPAL was reliable, and that scoring was consistent
across clinical trial protocols and across sites” (Smuck et al., 2011, p. 81). Their analysis of the
scores from 176 OPAL assessments left them to conclude that a variance of up to 1.5 between
the scores was acceptable, with only two trials shown to have a variance of 3.5. The
acceptability of a 1.5 variance was based on the research practice models of each site and
correlative studies associated with the protocol. Their review of the scores revealed that
misinterpretation of the definitions of the parameters used to rate the complexity levels resulted
in higher OPAL scores. Hence, they emphasized that “OPAL needs to be applied consistently at
the site and should be based on local practices to produce measurable site workload information”
(Smuck et al., p. 81). At the conclusion of their pilot project OPAL was revised to more
accurately reflect the clinical trial activity reported by the sites. OPAL provides “an objective
method of quantifying clinical trials activity on the basis of factors that contribute to increased
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workload,” however, “total workload of staff varies, and workload needs to be reviewed
quarterly to reflect fluctuation in cases” (Smuck et al., 2011, p. 83).
Sarmento and Silvino (2017) conducted a Portuguese transcultural adaptation and
validation study of OPAL. They indicated that because of the significant increase in the growth
of clinical research in Brazil the development of indicators that can inform about the quality of
work, support evaluation of performance and necessary changes to the existing processes is
essential. Due to lack of any instruments to measure workload of clinical research coordinators
in Brazil, they aimed to test a transculturally adapted version of OPAL to verify its validity and
reliability. Their goal was to be able to better distribute oncology trial protocols among clinical
research coordinators that would facilitate them to fulfill the requirements for the trials, as well
as identifying the capacity that would require redistribution of protocols and competency training
of staff. Their methods included front and back translation of the OPAL tool in Portuguese and
conducting a pre-test of the adapted instrument on 15 fictitious protocols in order to define the
workload score to set as the gold standard for evaluating the psychometric capacity of the
instrument. The final version of the adapted instrument was analyzed to measure the
psychometric capacity of the instrument – both reliability and validity of the tool. The numerical
data were analyzed using descriptive statistics and concordance of workload scores pertaining to
different observed items using inferential statistics, with a 95% confidence interval. Analysis of
concordance of observed items included the differences of intra- and inter-observer variability
against the average result. The result of their analysis showed a significantly high intra- and
inter-observer concordance (p<0.0001). The intra-observer analysis resulted in a high level of
concordance with ICC scores between 0.987 and 0.934 indicating high reliability. The interobserver analysis showed high level of concordance compared to the gold standard with an
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ICC>0.949 that demonstrated high level of validity of the score. They acknowledged that the
absence of a validated tool to calculate workload can result in unrealistic expectations,
unmanageable workload and inefficient use of available resources. They concluded that although
the adapted OPAL tool met the needs of the users in calculating workload, it is important to be
used consistently and that managers allocating protocol assignments evaluate other factors that
affect the work of clinical research staff.
In a study conducted by Milani et al. (2017), they tested the application of the Nursing
Time Required by Clinical Trial–Assessment Tool (NTRCT-AT). This was a single center study
in which the aim was to evaluate this tool as a means to measure workload expressed in time
spent to complete trial associated core activities. They identified 30 clinical trial core activities,
with 11 related to the trial activation phase and the remainder to study conduct. These 30 core
activities were associated with the clinical research nurse’s role in coordinating activities of a
clinical trial. The NTRCT-AT measured the average times required to complete each of the core
activities – expressed as a standard coefficient of time required to perform each activity.
NTRCT-AT was used to calculate the total clinical trial nursing time required for coordinating
study activities for each study participant enrolled in the trial. They had five phases for study
implementation that included the identification of aims, determination of study methods,
identification of core activities from the literature and site staff experience, timing of each of the
core activities using an objective external observer, data collection and review of the standard
co-efficient of time for each activity to calculate average time it took in effort to coordinate the
participation of each individual participant. Their study showed that the earlier and more
advanced phases of the trials were similar in content – meaning the types of core activities were
similar. However, the timing and complexity differed due to the difference in the number of
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procedures among various study visit intervals, and the frequency of study visits between
different trials. The NTRCT-AT was geared for measuring time commitments of personnel
coordinating phase I and III trials. Their data showed that phase I trials required more time for
study staff to complete trial activities during the activation phase. However, a weakness of their
study was the lack of generalizability of their data since the study was only conducted in one
research facility. Nevertheless, their study illustrated that the increasing demands of clinical
research necessitated an adequate number of skilled and competent workforce to be involved in
each trial.
Good, Lubejko et al. (2013) acknowledged that “[c]oordination of an efficient, successful
clinical research program can be challenging” and is compounded by the “lack of resources for
quantifying clinical-trial associated workload to help guide staffing and budgetary planning” (p.
211). Therefore, the use of a tool that generates objective metrics to measure workload could
potentially increase clinical research program productivity, efficiency and quality of work, while
providing managers a guide for calculating staffing and budgetary requirements, as well as
evenly distributing work among staff resulting in job satisfaction (Good, Lubejko et al., 2013).
They described the evaluation of an acuity-based workload assessment tool developed and
implemented to facilitate assessment and balance of workload among research staff. The tool
known as the Witchita Community Clinical Oncology Program Acuity Tool (WPAT) was
developed by the Witchita Community Clinical Oncology Program (WCCOP). The tool
classified study participants into two categories, on a study or off a study. The total number of
on- and off-study patients constituted the overall workload. Additionally, protocols were
classified as either a treatment- or cancer-control trial and were assigned a score based on sixworkload determinants that included treatment complexity, study procedure requirements,
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treatment toxicity potential, complexity and number of data forms, degree of coordination
required and number of trial random assignments or steps. Development of the tool was based on
a patient classification system that was used to determine workload and staffing assignments.
The calculation of the acuity scores took place monthly and required multiplying the protocol
classification score for each study by the number of active patients from the study that was
assigned to staff. Acuity score calculations were conducted over a period of 11 years. Review of
the acuity scores over the 11-year period confirmed that the complexity of clinical trials had
increased – acuity for treatment trials by 65% from 1999 to 2009 and cancer control by 181% for
the same time period (Good, Lubejko et al., 2013). The number of newly enrolled and on-study
patients assigned per full-time staff decreased as result of continual monitoring of workload and
adjustment of workload based on acuity scores. This demonstrated that “[m]onthly monitoring of
individual as well as group average acuity scores provided management with the ability to
balance workload among staff” (p. 213).
Good, Hurley et al. (2016) described a project sponsored by the American Society of
Clinical Oncology to evaluate the feasibility and utility of a workload measurement tool that
applied “objective metrics toward documentation of work, and to provide clearer insight to better
meet clinical research program challenges and aid in balancing staff workload” (p. e536). Fiftyone community-based research programs representing 30 states participated in the project, which
took place over six consecutive months. According to Good, Hurley et al., a 2010 survey
conducted by the ASCO Community Research Forum not only reinforced the need for a method
to evaluate clinical trial related workload but was one of the top three of 12 proposed projects. In
response, ASCO formed a work group to develop such a tool. After conducting a review of the
literature and available tools the work group concluded that three characteristics of a workload
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measurement tool should be simplicity, reproducibility and long-term usability. “The project
focused only on clinical trial workload associated with patient-centered encounters or clinically
focused efforts, defined as any in person protocol-required evaluation and management visit that
was designated as required on the protocol study calendar/study plan,” but did not include
regulatory-based workload or other non-clinical elements related to clinical trial work (Good,
Hurley et al., 2016, p. e537). Two interrelated tools were used for the project: ASCO Protocol
Acuity Scoring Worksheet, ASCO Clinical Trial Assessment Tool. The ASCO tool was based
on the WPAT (previously described) that had been in use for more than ten years. The acuity
scoring worksheet, which consisted of a 4-point rating scale, would be used to calculate the trial
complexity level from the least complex to the most complex. The assessment tool was a webbased platform used to collect individual protocol and individual staff acuity scores but was
programmed to use full-time equivalent (FTE) status instead of workdays per week used in the
WPAT model. The protocol acuity score was multiplied times the number of patient encounters
for each specific trial then was divided by the staff FTE value to yield the individual staff acuity
score. Descriptive statistics accounted for self-reporting of data by all participating programs,
and frequencies and percentages were used to summarize their findings. Additionally, to account
for the heterogeneity of the participating program’s characteristics, the programs were grouped
into categories to separate them by type and size of the program. Only FTE data were used to
summarize staff acuity scores and patient encounters for each group and “data were reported as
medians and ranges by patient status, trial sponsor, type of trial and staff title” (Good, Hurley et
al., 2016, p. e538). Ninety percent of the 51 research programs that participated provided all six
months of workload data, two sites provided five months of data and three sites provided two,
three, or four months of data respectively. The research programs reported a median accrual of
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150 patients into clinical trials overall and a median of 37 open and actively enrolling trials.
They “contributed clinical trial-associated workload data for 323 staff members in total…which
represented 963 unique protocols and 165 unique sponsors” (Good, Hurley et al., 2016, p. e539).
Six percent of the 323 staff members identified as teams of staff consisting of multiple members.
Congruency in the assignment of the same protocol acuity rating was found for 461 protocols but
a 1-point difference in 120 protocols and 2-point difference in 23 protocols were found.
Variability in assigned acuity rating scores were found in 36% of industry trials, 17% of
federally sponsored trials, 3% of academic-sponsored trials and 4% of trials with other sponsors
(P<.001). The median acuity rating assigned to treatment trials was 3, cancer control trials was 2,
correlative science trials was 1.5 and observational/registry trials was 1. Across all groups the
highest median staff acuity scores were for those who had patients who were on study and
receiving treatment relative to those with patients only on study follow-up. Higher median staff
acuity scores were seen in treatment trials, compared to cancer control, observational/registry
and prevention trials. Industry trials yielded higher median staff acuity scores than trials that
were federally sponsored, academic-sponsored or had other type of sponsors.
According to Coffey et al. (2011) “[t]he increasing use and complexity of multi-modality
treatment regimes, the rising costs of clinical trials, the emphasis on the efficient use of available
resources and adherence to Good Clinical Practice (GCP), and increasing regulatory
requirements and demands for quality assurance/control, have resulted in an increased focus on
workload issues” (p. 36). They indicated that the use of unproven methods or simple estimation
for measuring workload may result in unrealistic expectations, excessive workload or inefficient
use of resources. They described a pilot study of the Workload Measurement Instrument (WMI)
that was developed because of the recognition of the importance for understanding the tasks,
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time requirements and resources involved in effectively and efficiently conducting clinical
research. The WMI “was seen as a means of providing a tool by which individuals could
estimate more accurately the time and resources required to participate in clinical trials” (Coffey
et al., 2011, p. 36). The development of this instrument involved seven stages leading to the
finalization of the trial related tasks to be assessed. The instrument applied concepts from two
prior instruments that individually assessed workload and complexity of a trial. The WMI
instrument developers divided the instrument into four modules representing the planning,
implementation, data management and study close-out phases of a trial. Next, they applied the
complexity rating dimension to the instrument. They further subdivided the implementation
module into recruitment/treatment and treatment/follow-up to facilitate validating and linking the
workload measurement with the complexity dimension. The prospective study only focused on
research related activities and not those considered as clinical standard of care. Workload was
only assessed for clinical research coordinators to keep participant characteristics homogenous
and to facilitate collection of more precise workload data. Data collection was completed over a
six-month period. The findings confirmed that all tasks and subtasks within modules 1, 2, 3 were
valid, and what tasks or subtasks were completed more and less frequently for modules 1, 2a, 2b
and 3. Analysis of the data from modules 4 were not described because of the small number of
studies that were in this phase. The aim of this prospective study was focused on validating what
trial related tasks both increased the trial’s complexity and workload for each of the four phases
of the trial conduct included in the modules. The purpose of the WMI was to determine what
tasks or subtasks occurred in each of the four phases to allow examination of workload and
complexity to inform on multiple different levels.
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Several studies or pilot projects involving the testing of a workload measurement tool
were described. Of these two were level II high quality quasi-experimental and four were level
III good quality non-experimental studies. Despite that some of the pilot testing took place across
multiple research facilities, none of their findings were considered generalizable, and emphasis
was made for the application of these tools to reflect the heterogeneous characteristics of the
research facility to ensure meaningful measurements of workload. Across all the studies, the
tools used objective quantitative measurements to calculate trial complexity and workload. The
literature suggested that complexity and workload measurement tools are useful in determining
workload capacity for different phase trials, estimating staffing and budget requirements and for
allocating more balanced workload for research staff. Measurement indicators used to calculate
workload are essential in informing about the quality of work, efficient use of staff resources,
necessary changes to existing processes, competency training related to trial task requirements
and for supporting the evaluation of clinical trial performance. The literature confirms phase I to
be the most complex level of trials.
Theoretical Framework
Two conceptual models were utilized as the framework for the development and
implementation of this pilot project. The Institute for Healthcare Improvement (IHI) Model was
used to guide the development of the project aims. This model incorporates the use of Plan-DoStudy-Act (PDSA) cycle for testing and studying the change for improvement (Appendix C).
IHI Model for Improvement
The three fundamental questions from the IHI model guided the development of the
project aims, measures to determine if change leads to improvements and changes to implement
that result in process improvement (Institute for Healthcare Improvements, n.d.). Utilizing the
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PDSA cycle, the IHI model outlined four main components for the iterative process for testing
and studying the change – the use of a quantitative workload measurement tool to assess trial
complexity and workload.
•

Step 1 (Plan) involves planning of testing and observation that includes a data
collection plan

•

Step 2 (Do) involves small-scale testing of an intervention or change in process

•

Step 3 (Study) involves time to analyze the data and study the results

•

Step 4 (Act) involves making refinements to the intervention or process change based
on information learned from the test (Institute for Healthcare Improvements, n.d.).

Plan-Do-Study-Act
According to Coury et al. (2017), the PDSA cycle is a commonly used model for
implementing small tests of change to optimize process improvement in health care settings that
might have untapped potential for pragmatic research. In contrast to clinical trials which
“emphasize internal rather external validity, using highly controlled environments and selected
populations…pragmatic studies are generally embedded in care delivery environments,”
therefore making this an ideal model to use as the strategy for implementation of this pilot
project (p. 2). Its advantage is it allows evaluation and refinements of an intervention to be made
soon after it is implemented.
Taylor et al. (2014) cited that there is mixed evidence on effective quality improvement
interventions and many have concluded that such interventions may only be effective in specific
settings. Additionally, they indicated that research findings emphasized the effect that the local
context has on the success of an intervention, citing that stand-alone interventions are unlikely to
deliver consistent improvements and instead require multi-faceted approaches that are developed
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iteratively to adapt to the predictable and unpredictable changes that occur over time and within
a complex social system. They further cited that the PDSA cycle is one such method for an
iterative development of change, either used by itself or as part of a wider quality improvement
approach, such as the IHI Model for Improvement (Taylor et al., 2014).
Methodology
Using the PDSA cycle, project implementation was divided into two stages. The first
stage was project planning and the second was the implementation stage. During the planning
stage, the project stakeholders were identified, the aims and objectives were developed,
stakeholder roles, responsibilities and project timelines were established, the data collection plan
was created, workload measurements for two sample protocols were performed and adjustments
were made to the data collection plan and elements of the tool based on the initial measurements
performed.
The following were completed during the implementation stage: measurement of trial
complexity and workload was completed for ten protocols that were active between 2011 to 2019
inclusive, a job stress survey of the clinical trials unit personnel, and a review of protocol
deviations reported for the ten protocols from the project sample.
Project Setting & Population
The pilot project was conducted on a moderate sized clinical trials unit located within an
academic and tertiary healthcare institution. The unit consisted of three research managers, five
clinical research nurses (CRN) and ten clinical research coordinators (CRC). The research staff is
responsible for coordinating trials that were mostly phase I and investigating the use of cellbased immunotherapies to treat patients with advanced stage cancer. Trial conduct involved
physician investigators, multidisciplinary clinical teams, study sponsor teams (e.g., project and
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data management), and three institutional oversight committees. Technical assistance was
solicited from the institution’s Quality Improvement consultant for advice on certain elements
related to the project, such as Lean principles and how to perform time measurements of work
activities. A staff statistician was also consulted for advice on data collection and interpretation.
Project Feasibility
The Institutional Review Board of record (i.e., University IRB) granted an exemption for
this quality improvement (QI) project. The project site’s IRB deferred to the IRB of record for
the exemption for this QI project. The department of nursing education for the project site
concurred with the project site’s IRB and permitted the project to proceed as planned.
Additionally, the project aims and its implementation received the support from the project
lead’s executive deputy director who functioned as the residency preceptor and the personnel
from the clinical trials unit who were stakeholders for the QI project implementation.
Minimal expense was incurred for this pilot project. All of the data collection worksheets
and instruction guides were created with Microsoft (MS) Word, and data were entered into MS
Excel for the eventual data review and interpretation. This software application was a work
issued tool that was available to the project lead, research managers and research staff prior to
the start of the project and therefore did not generate any additional expenses.
There were some anticipated barriers for the implementation of this pilot project. The
integration of project activities into the existing workflow of the research managers and staff
(i.e., CRNs, CRCs) who had many competing work priorities was a concern. As stakeholders
they participated in the development of the data collection tools and participated in data
collection and other project related activities. These barriers were mitigated with scheduled
project meetings and use of data collection tools that could be completed electronically and
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remotely during the approximately two-month period when the data collection occurred. The
completion of data collection was not extremely time consuming for the stakeholders nor were
these extremely time sensitive. The data collection activities for this project were completed in
approximately two months with all of the actual data collection being completed remotely. The
research managers and staff had access to the unit’s trial master files and share drive via secure
remote access that facilitated their ability to complete their administrative work duties and
project related data collection off site.
The other anticipated barriers were confidentiality and intellectual property concerns.
Confidentiality considerations pertained to the staff who participated in the pilot project, as well
as with the use of study participant information. To maintain anonymity of staff and study
participants only deidentified data were used for data collection. The project site’s legal
representative confirmed that there was no intellectual property issue since this was not a
research project.
There was also an ethical concern related to the potential risk for bias because of the dual
role I had as the director of the unit and graduate student conducting the QI project. It was
crucial that my role as the director did not intersect with my role as the project lead. This was of
primary concern with the workload survey category pertaining to job satisfaction. To reduce
bias, stakeholders were involved with the development of the data collection tools pertaining to
workload measurement to ensure that it represented the specific needs of their unit. Objective
tools such as OPAL and an established job stress survey available in the public domain were
used to collect data for workload measurements and job stress factors. With respect to the
survey, steps were taken to preserve the anonymity of the respondents by having them return
their completed questionnaire via email. The questionnaire which did not include any identifiers
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were then immediately saved into an electronic folder and the email was then deleted. The
review of the responses took place after all of the completed questionnaires were filed. The
demographic questions included in the survey pertained to educational background and research
experience and did not include questions that would likely disclose the identity of the
respondents.
The COVID-19 pandemic occurred at the onset and persisted throughout the duration of
the data collection for this project. Due to many significant changes to the institution’s clinical
workflows resulting from the pandemic and social distancing requirements, the time study
component for this pilot project was permanently eliminated. Other components for the project
were unaffected by the COVID-19 crisis.
Trial Complexity & Workload Measurement
A comparison was made between the various instruments studied to measure trial
complexity and workload in the clinical trial setting from the description in the literature. OPAL
was selected as the tool for this pilot project based on the guiding principles that it was easy to
use, adaptable to the local context of the clinical trials unit where the project took place, and
measured trial complexity. Three measurements were generated using OPAL: trial complexity,
case workload, and total workload. Workload measurements were performed by two of the unit’s
research managers for ten clinical trial protocols using OPAL. They collaborated with the
project lead in recreating the list of central processes (CP) and special procedures (SP) to reflect
the trials in our unit (Appendix B). They performed initial measurements for two trial protocols,
then met with the project lead to discuss modifications necessary for clarifications for the
calculation of case workload. Refinements to both the workload measurement worksheet and
instruction guide were made to facilitate this need.
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A trial complexity score was assigned to each of the ten protocols using the OPAL
pyramid scale (Appendix D). The pyramid scale complexity level is based on the phase of the
trial and a set of criteria that include the number of occurrences of SPs and CPs. We modified the
list of CPs and SPs to make it more representative of the trial activities for our unit.
The original calculation for case workload involved multiplying the OPAL complexity
score by the number of study participants in either the active or follow-up phase of the trial.
Calculation of the total workload involved the addition of the OPAL complexity score plus the
case workload score. The case workload score represented patient management and the total
workload score was associated with study management. For the convenience of the pilot testing
of OPAL we multiplied the complexity by only the number of patients for the trial sample size.
We were interested in learning if we could better assess the trial complexity by adding
points for every occurrence of a SP that we identified as unique to certain protocols (Appendix
B). We modified the calculation of case workload by adding the complexity score plus the
additional points for SP and multiplied this by the number of patients for the trial sample size
yielding new case workload scores for the ten protocols in our sample.
Protocol Deviations
In parallel, additional stakeholders were also solicited to participate in data collection of
protocol deviations that were reported for each of the ten trial protocols from our sample. An
index of all protocol deviations was available from each protocol’s trial master file. The
regulatory manager from the unit created copies of the tables that indexed all of the protocol
deviations that were reported to date. Review of protocol deviations was an important concept
for examining errors made during protocol execution that would inform about factors affecting
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accuracy, competency of staff and factors that contribute to work stress. We also wanted to learn
if any of the deviations impacted patient safety or study outcome.
Job Stress Survey
A workload survey was assembled using four categories from a job stress questionnaire
created by the National Institute for Occupational Safety and Health (NIOSH) that was available
in the public domain. The NIOSH Generic Job Stress Questionnaire is a validated instrument that
included multiple dimensions of job stress that could be used in total or individually to construct
a separate survey questionnaire. Four categories from this instrument were used to develop the
workload survey for this project.
•

Job Requirements

•

Workload and Responsibility

•

Mental Demands

•

Job Satisfaction

Questions from the NIOSH instrument representing these dimensions were included in
the survey. The intent of the survey was to examine if there were any correlations between the
responses to the survey and factors impacting workload. In particular, this was related to the
impact on staff efficiency and work stress. Instructions accompanying the survey questionnaire
was emailed to 18 staff members of the clinical trials unit. The questionnaire was designed to be
completed electronically and returned to the project lead via email. The questionnaire did not
require any identifiers that would discourage honest responses to each of the questions, most
especially those pertaining to job satisfaction. A minimal amount of demographic information
pertaining to educational background and research experience was queried on the survey but
none that would likely compromise the anonymity of the respondents. The participants were
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requested to return their completed survey form via email and each form was blindly copied
from the email into an electronic folder and were assigned a file number based on the sequential
order in which these were received. This was to keep accounting of responses for follow-up
purposes. The email from the participant was deleted after their completed questionnaire was
filed. All correspondences related to the survey were conducted using the project lead’s school
email account.
Outcomes Measurement & Findings
The outcomes and interpretation of the findings were guided by Lean principles.
According to Sweeney (2017), Lean incorporates the “philosophy of kaizen, or the creation of a
culture of continuous improvement” (p. 9). In measuring the outcomes of our aims and
interpreting the findings we utilize the concepts of Muda, Mura and Muri from Lean to focus our
attention on the opportunities for process improvement changes. Each of these concepts of Lean
addresses fundamental areas for process improvements. “Muda represents waste in its most
physical form,” and “[t]he objective with waste reduction and elimination is to clearly separate
the value-added activities that are identified as wasteful or non-value-added” (Sweeney, 2017, p.
7). “Mura is waste in the sense of unevenness,” because “[u]nevenness in workflow can result in
unnecessary downtime or periods of unnecessary stress on equipment, systems, and workforce”
(Sweeney, 2017, p. 8). “Muri is a failure to understand capabilities or to succumb to the effects
of overburden” (Sweeney, 2017, p. 8).
Objective 1/Outcome 1
The first thing we were trying to accomplish was to show that we could measure trial
complexity. We used OPAL to measure complexity for ten trial protocols that were conducted
between 2011 and 2019 inclusive. What we learned was that we could determine trial complexity
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using OPAL. Of our ten trial protocols, six were phase I, one was phase I/II and three were phase
II. All phase I and I/II trials scored a complexity level of eight (8) that was consistent with the
literature noting phase I trials as the most complex. It is also notable that most of the trials
conducted in this research unit are phase I trials.
Objective 1/Outcome 2
We wanted to see if the number and frequency of trial procedures affected the complexity
and workload scores. We completed two calculations for case workload using the original and a
modified formula to generate original and new workload scores. What we found was that the
new workload scores were greater than the original case workload scores with a mean of 416.5
and 173.2 respectively (Table 1). The modified calculation for case workload then resulted in
higher total workload scores.
Table 1
Case Workload Scores

Mean
Median
SD
Minimum
Maximum

OPAL

Original Case
Workload

7.70
8.00
.483
7
8

173.20
164.00
54.121
98
264

Original
Total
Workload
180.90
172.00
54.098
105
272

New Case
Workload

New Total
Workload

416.50
419.00
178.727
201
792

424.20
427.00
178.854
208
800

We measured the difference between the original and new case workload scores using a
paired t-test. To illustrate the difference, we plotted that scores on a graph (Figure 1). The paired
t-test strongly suggests a highly significant difference in the mean values of the two scores with a
P<.001. This suggested that the new case workload scores captured the true complexity of these
trials.
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Objective 1/Outcome 3
We were also interested in learning if we could create a threshold representing an
Figure 1
Original & New Case Workload Scores

Note. Y-axis shows the range of case workload scores. X-axis shows the original and new case workload scores for
all ten trial protocols from our project sample.

acceptable distribution of work. We plotted the mean case workload scores and values of 1 SD
and 2 SD on a graph (Figure 2). Using a random selection of two case workload scores from our
sample of ten trials we calculated the workload scores for four simulated CRCs and plotted this
on the graph to see whether the simulated workload scores were extreme (above 1 SD) or
acceptable (within 1 SD). If scores lie within 1 SD of the mean this suggested an acceptable
distribution of work, while those above would be considered extreme. To note, since our project
sample only contained ten trial protocols the scores were not precise so measurements should be
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replicated using a larger sample. Nevertheless, we were able to obtain useful information to
inform on a balanced distribution of work.
Objective 2 Outcome
We wanted to identify three factors that impact staff workload. When we examined the
original case workload against the new workload scores (Figure 1), we saw a significant increase
in the scores, on the average a 2.3-fold difference suggesting the volume and frequency of trial
procedures likely contribute to increase in workload. From our paired t-test complexity of trial is
another factor.
Figure 2
Workload Threshold

Note. Y-axis represents the range of case workload scores. X-axis represents the clinical research coordinators
(CRC) simulated case workload scores.
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Objective 3 Outcome
We wanted to identify four factors that affect efficiency and contribute to job stress. We
conducted a workload survey that collected a limited amount of demographic data pertaining to
staff educational background and work experience. The largest proportion of staff had either a
healthcare or science related background. Of these two groups, most of the staff with healthcare
background had prior jobs in clinical research and 6 to 10 or greater years of experience in
clinical research.
Below were the more frequent responses from the job requirement category of the survey
(Appendix E). The more extreme of these responses are in bold. We interpreted these responses
to mean that although their job was challenging, their skills were often matched with the tasks
they needed to complete, suggesting that skill level should match the complexity of the work
tasks to be efficient.
•

~ 47% = required to work fast sometimes

•

~43% = required to work hard fairly often

•

~37% = had little time to get things done sometimes

•

~41% = had a great deal to be done sometimes

•

~41% = had a great deal to be done fairly often

•

~58% = had marked increase in workload sometimes

•

~43% = had marked increase in amount of concentration required on the job
fairly often

•

~43% = were given a chance to do the things they do best fairly often

•

50% = used skills from previous experience and training fairly often
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The responses from the workload and responsibility category (Appendix F) indicated that
although ~62% of the staff in this unit had a lot of work, 50% of them had a lot of time to
complete their work suggesting that there is an even distribution of work. Fifty-nine percent
indicated having a lot of projects, assignments or tasks suggesting that this may be an area
requiring further examination of skill-mix.
•

50% = experience a little slowdown in workload

•

~68% = have some time to think and contemplate

•

~62% = have a lot of workload

•

50% = have a lot of time to do all their work

•

~59% = have a lot of projects, assignments or tasks

•

~56% = have some lulls between heavy workload periods

From the mental demands category (Appendix G), approximately 68% indicated that
their job required a great deal of concentration and about 80% were required to remember many
different things. We interpreted this to mean that although their workload is likely balanced their
work is very challenging and complex.
With respect to job satisfaction (Appendix H), 50% indicated they were very satisfied and
the other 50% indicated they were somewhat satisfied. Approximately 87% indicated that they
would take the same job over again and 68% would choose a similar job if they had other
choices. This suggested that their current work and workload were not affecting overall job
satisfaction.
When we reviewed the protocol deviations that were reported for four of the ten protocols
from our project sample, we noted that the higher numbers of deviations pertained to missed tests
or procedures and study visits or procedures completed outside of the protocol specified window.
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This suggested that the volume and frequency of protocol required tests and procedures affected
the accuracy and efficiency of the staff’s work performance. This is consistent with the literature
that indicated that humans who are overburdened with work may hurry their performance,
commit more errors and have poor awareness of their surroundings. It is notable that none of
these protocol deviations were determined to affect patient safety or study outcome.
Objective 4 Outcome
What we learned from our findings is that the volume, frequency and complexity of trial
work activities does affect the clinical trial performance in our unit. This was evident from our
workload assessments, as well as the number of protocol deviations that we noted from our
review. We also learned that the volume of work, complexity of trial related tasks, aggressive
timelines, prior work experience, skill level and strategic use of staff skill mix should be factors
to assess because they do impact staff efficiency and can contribute to work stress. For example,
matching skill level to the complexity of the task required for staff to complete would result in a
more efficient use of staff resources. We also learned that there is value in using quantitative
measurements to assess workload. More importantly we learned that use of established
conceptual models such as the IHI Model for Improvement, PDSA and Lean are more reliable
and sustainable methods for testing and studying change directed at process improvements.
As a result of our pilot project, we are piloting the use of a staff effort calculator that we
created using MS Excel. The calculator is used to calculate staff effort dedicated to each of their
assigned protocols based on hours worked in a 40-hour week. This calculator can also be used to
perform a cost benefit analysis for staffing requirements based on the skill level required for the
role and responsibilities for each trial protocol.
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Limitations
The overall limitation for this pilot project was the limited sample size of the protocols
used for measuring trial complexity and workload. We also did not calculate case workload
using active and follow-up patients actually enrolled in the trials. Another limitation was that we
only measured trial complexity but not the complexity of the individual tasks themselves. This
would be informative in determining whether volume of work, the complexity of the task or
both, impact clinical trial performance and efficiency. We also had time restrictions for
completing repeat testing of the tool and performing additional measurements. Finally, due to
concerns of confidentiality the responses to the survey pertaining to job satisfaction may not
have been as candid.
Conclusion
The most important lesson we learned from this pilot project was that there are
established and more exquisite methods for testing and studying changes for process
improvement. I recommend that concepts from the IHI Model for Improvement, PDSA and Lean
be used in this unit for implementation and evaluation of process improvement changes as these
are more sustainable comprehensive methods in comparison to single-bullet approaches.
Consistent evaluation of our operational model needs to be conducted to determine when process
improvement changes are warranted. Use of quantitative methods to calculate staff effort and
work capacity will result in more accurate estimation of staffing and budgetary requirements.
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Appendices
Appendix A
Key Literature Synthesis and Appraisal
Author
Smuck et al. (2011)

Title
Ontario protocol assessment level:
Clinical trial complexity rating tool
for workload planning in oncology
clinical trials.

Synthesis
• Aim - to demonstrate that OPAL
was reliable, and scoring was
consistent across clinical trial
protocols and trials sites
• OPAL workload measurement
tool that rated protocol
complexity based on a pyramid
scale and calculated workload
scores
• Tool developed by experience
group of clinical trial managers
• Guiding principles for tool
development were – easy to
apply, measured work of clinical
trial professionals, useful for
calculating workload capacity,
included all trial phases, and not
intended for academic review
• Complexity levels based on trial
phase and protocol activities –
central processes and special
procedures
• Calculation of workload score
based on OPAL complexity level
• Tool tested in 17 participating
cancer clinical trials sites with
heterogenous characteristics
• 176 OPAL assessments were
completed for 27 protocols

Findings
• From the 176 assessments
completed, analysis of the score
variance of 1.5 was considered
acceptable on the basis of
research practice models and
participation in correlative
studies
• Two trials were rated with a
variance of 3.5
• Misinterpretation of the
definition of special procedures
produced higher OPAL scores
that indicated that OPAL needs
to be applied consistently at the
site and be based on local
practices to produce measurable
site workload information

Appraisal
Level III – Good Quality
Non-experimental study
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Author
Sarmento & Silvino (2017)

Title
Measuring workload of clinical
trials: Transcultural adaptation and
validation to portuguese language of
Ontario protocol assessment level
(opal).

Synthesis
• Aim – to perform Portuguese
transcultural adaptation and test
its validity and reliability
• OPAL tool translated to
Portuguese
• Pretest of translated tool
performed on 15 fictitious
protocols to define workload
score to set as the gold standard
for evaluating psychometric
capacity of the tool
• Final version tested for reliability
and validity
• Numerical data analyzed using
descriptive statistics
• Concordance of workload scores
pertaining to different observed
items analyzed using inferential
statistics
• Confidence interval 95%

Findings
• Analysis of concordance of
observed items included
differences of intra- and interobserver variability against the
average result
• High intra- and inter-observer
concordance (p,0.0001)
• High level of intra-observer
concordance with ICC scores
between 0.987 and 0.934
• High level of inter-observer
concordance compared to the
gold standard score with an
ICC.0.949 demonstrating high
level of validity of the score.
• Concluded after analysis that
adapted tool met the needs of the
users in calculating workload but
needs to be used consistently and
other factors that affect work
must also be evaluated

Appraisal
Level II – High Quality
Quasi-experimental study

Milani et al. (2017)

How many research nurses for how
many clinical trials in an oncology
setting? Definition of the Nursing
Time Required by Clinical TrialAssessment Tool (NTRCT- AT).

• Aim – to evaluate NTRCT-AT as
a means to measure workload
expressed in time spent to
complete trial associated core
activities
• Time measurements used to
calculate total clinical trials
nursing time required per patient
enrolled in a trial
• Participants comprised of 7
Italian clinical research nurses
• Research nurse team identified
aim and study methods
• A list of 30 core activities were
selected for time measurements –
11 pertaining to study activation
and the remaining to study
conduct
• Time measurements of core
activities performed by
independent observer
• Pilot testing conducted in one
research facility
• All activities were timed for all
research nurses to reduce
individual variability

• Compared the total nursing time
required by the trials annually
(1,254, 578 minutes/year) with
the total number of working days
required in theory and the actual
worked days showed a greater
theoretical workload in hours per
year (average 11.13 hours for
one year assessed)
• The research nurse participants
felt this to be an accurate
reflection of their current
situation of excessive workload
and difficulty in carrying out all
necessary activities

Level III – Good Quality
Nonexperimental study
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Good et al. (2013)

Title

Measuring clinical trial-associated
workload in a community clinical
oncology program.
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Synthesis
• Tool tested retrospectively on
141 clinical trials
• Provides a quantitative
measurement of workload that
trial work activities represent in a
workday

Findings

Appraisal

• Aim – to evaluate an acuity-based
workload measurement tool
(WPAT) developed by WCCOP
• Patient Classification - classified
trial participants into two
categories – on-study or off-study
• Total number of on- and offstudy participants constituted the
overall workload
• On-study group subcategorized
into active treatment and offtreatment
• Protocol Classification – protocol
classified as either treatmentfocused or cancer control-focused
and ranked based on 6 workloadrelated determinants
• Acuity scores assigned to
individual clinical trials
according to their estimated
workload ranging from 1observational, 2-requiring oral
agents with minimal toxicity
potential, 3-chemotherapy with
increased toxicity potential,
complex drug regimens high
toxicity potentials
• Calculated individual research
nurse workload scores monthly
for 11 years by multiplying
number of patients per trial by the
assigned acuity score assigned to
trial

• Review of acuity score data
across an 11-year timespan
confirmed clinical trial
complexity had increased
• Treat-focused trials acuity scores
increased by an annual average
of 65% versus cancer controlfocused trials by 181% from
1999 – 2009
• Treatment trial 11-year average
acuity score was 30.6, with
annual average ranging from
19.3 to 45.6 between 2000 –
2008
• Cancer Control trial annual
acuity increased from 8.97 to
69.8 from 2001-2006
• Off-treatment acuity scores
showed a 178% increase from
2001-2009
• The number of new patient
enrollment and the number of
patients on and off study
increased over the 11-year
timespan but as a result of
monitoring workload and
adjusting staffing needs based on
acuity scores, the number of
patients per FTE research nurse
for new enrollments and patients
on study decreased. The number
of patients categorized as off
study only slightly increased.

Level III – Good Quality
Nonexperimental study
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Author
Good et al. (2016)

Title
Assessing clinical trial-associated
workload in community-based
research programs using the ASCO
clinical trial workload assessment
tool.

Synthesis
• Aims – to test a combination to
two interrelated tools measuring
protocol complexity and
workload effort for clinical trials
across multiple practice settings
known as Clinical Trial
Workload Assessment Tool
• Two interrelated tools: ASCO
Protocol Acuity Scoring
Worksheet incorporated a 4-point
protocol complexity rating scale
where score of 1.0 = lower
complexity/workload to 4.0 =
complex trial with greater
workload. ASCO Clinical Trial
Workload Assessment Tool a
web-based platform facilitated
collection of clinical trialassociated workload data.
• 51 community-based research
programs representing 30 states
participated in this project
• Clinical trial-associated monthly
workload data were collected and
entered into the web-based tool
for 6 consecutive months
• Project tool used refined and
edited WPAT 4-point protocol
scoring criteria developed
previously by WCCOP
• Protocol complexity assessed
before assignment of protocol
acuity score
• Project tool accounted for two
acuity metrics – protocol acuity
and individual staff acuity scores
• FTE status was programmed to
be used instead of days worked
per week
• Patient encounters recorded in
tool as either on-study but off
treatment or off-study in followup
• Calculation of individual staff
acuity score: number of patient
encounters x protocol acuity
score/staff member FTE value =
individual staff acuity score

39
Findings
• Descriptive statistics were
computed for self-reported
program characteristics and
workload data, including staff
acuity scores and number of
patients encounters
• Self-reported characteristics of
the programs revealed a variety
of types of programs, various
degrees of experience and
accrual volumes
• 47% = federally funded
• 14% = community hospital
• 14% = non-academic hospitalbased private physician practice
• 22% = non-hospital based private
physician practice
• 2% = private research network
• 2% = other
• Clinical trials experience ranged
from 7 to 30 years
• Clinical trial accrual median =
150 patients
• Open trial median = 37
• Actively accruing trials ranging
from 9 to 186
• Research programs contributed
clinical trial-associated workload
data for 323 staff members,
including RNs (49%), CRAs
(28%), research coordinators
(16%), administrators/managers
(1%)
• Data represented 963 unique
protocols of which 604 observed
patients on study treatment
• Data represented 165 unique
sponsors
• 6% of staff identified as “teams
of staff that included multiple
members
• Participating program were
shown to be congruent in
assignment of same protocol
acuity rating to 461 protocols
with patients on study treatment
(76%)

Appraisal
Level II – High Quality
Quasi-experimental study
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Author

Coffey et al. (2011)

Title

Workload measurement instrument.
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Synthesis
• Project only focused on core and
consistent elements rather than all
elements of the clinical trialassociated workload

Findings
• A difference of one point was
found in 120 protocols (20%)
• Two-point difference reported in
23 protocols (4%)
• Variability in assigned scores
found in 36% on industry trials,
compared with only 17% of
federally sponsored trial, 3%
academic-sponsored trials and
4% of trials with other sponsors
(P,.001).
• Median acuity ratings assigned to
treatment trials was 3; cancer
control trials assigned median of
2, correlative science trials
assigned a median of 1.5 and
observational/registry trials a
median of 1
• 96% of the 51 participating
programs provided at least 5
months
• Response rate along with
feedback form participants
demonstrated that the tool was
simple and easy to use and
supported long-term feasibility
and utility for community-based
research programs and also
minimized bias in the findings
• Results support the idea that
complexity of trial affects the
work associated with trials
• Establishing single-benchmark
acuity score associated with
number of patient encounters for
FTE staff member to use as
reference for community-based
research programs required
grouping programs under similar
categories to allow comparison to
the most applicable or similar
types of program
• Provides preliminary
understanding of the complexity
of the measurement of clinical
trial-associated workload

• Aim – to collect data using
Workload Measurement

• Total of 414 modules were
completed from 27 hospitals

Appraisal

Level III – Good Quality
Non-experimental study
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•

•
•
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•

•

Synthesis
Instrument (WMI) to validate the
four WMI modules linked to a
previously developed trial
complexity assessment tool
WMI developed in 7 stages: 1development, 2-validation, 3revision of draft check list of trial
related activities, 4-drafting of
the WMI, 5-feasibility pilot
study, 6-analysis, 7-revision of
trial related tasks incorporated
into the 4 modules
Prospective study focused only
on research related activity and
not those considered routine care
Workload only recorded for
research staff working on trial
and excluded investigators,
pharmacists, day care staff, etc.
due to belief that it would be
difficult to collect accurate data
from such a diverse range of staff
– accepted limitation of study
Four WMI modules: Module 1planning stage, Module 2implementation stage, Module 3trial data management stage,
Module 4-closure/final stage
Module 2 further subdivided in
2a-recruitment and 2btreatment/follow-up
Data collection occurred over a
6-month period
Modules 1 and 4 included any
trials in planning and closure
stage due to the small number of
trials likely to be these stages
during the 6-month data
collection period
Modules 2 and 3 included trials
covering as many tumor types,
treatment modalities and study
types to ensure an inclusive range
of study activities
36 studies were included in the
prospective study
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•
•

•

•

•

•

Findings
covering 12 UK cancer research
networks
Data completed for 35 of the 36
trials included in study
Three centers did not complete
the modules due to merger of
networks, staff shortage or
excessive workload issues
Assumption were made that
research staff were experienced
and trained; not involved in
actual delivery of treatment;
research activity was additional
to standard treatment; hospital
support services, standard
equipment was
available/accessible to staff
Module 1 = most frequently
completed subtasks were those
related to preparation/submission
of documentation to ethics
committees; lowest recorded
tasks related to organizing and
attending meetings other than inhouse meeting for information,
training, and trial activation
Module 2a = most frequently
completed subtasks related to
screening for eligibility,
informed consent, and sample
preparation – consistent with
expectations and personal
experience of the project
participants; least completed
subtask was coordinating and
verifying radiotherapy dose
reductions and missed treatment
– anticipated given very low
numbers of radiotherapy trials
included in the study
Modules 2a, 3 = most frequently
completed subtask was
completion of case report form,
photocopying/sending trial
documents, preparation and
submission of trial amendments
and updating study documents
following amendments

Appraisal
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Author

Title

Synthesis
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Findings
• Two major revisions to WMI
were identified as important: 1st
change related to recognition of
importance given to
administration and
communication by the
collaborators and added as
subtasks in modules; 2nd
recombination of modules 2a and
2b with specific sections related
to consent, treatment and followup incorporated into Module 2

Appraisal

A MEASURE TO DETERMINE ACCEPTABLE WORKLOAD
Appendix B
List of Central Processes and Special Procedures
Central Processes
OPAL score accounts for the items below
•
•

•
•
•
•
•
•
•
•
•
•
•
•
•
•

Special Procedures
One (1) point will be added to the OPAL
score for each timepoint requiring the items
below
Protocol and Informed Consent Form
• Antigen Expression Testing
review
• Bone Marrow Biopsy
Submission to Institutional Committee(s) • Tumor Biopsy
for review/approvals: initial review,
• Nuclear Imaging
amendments, continuing reviews,
• Neuro Evaluation
reportable events, exceptions/deviations
• Insertion of specialty catheter for
Study related training (e.g., SIV, EDC)
intrapleural, intraperitoneal or
Triaging study related patient and
intratumoral administration of IP
provider inquiries
• Administration of IP – intrapleural and
Screening and enrollment of subjects
intraperitoneal infusion or intratumoral
Scheduling study patient visits
injection
Coordinating study related procedures and • Lymphodepleting chemotherapy
visits
• Retreatment – planned retreatment of IP
ECHO/MUGA
after the initial study treatment at Day 0
Insertion of apheresis catheter
• Fractionated dosing or multiple
administration study visits
Leukapheresis
Administration of Investigational Product • Multiple treatment cohorts
(IP) – intravenous infusion
Preparation for monitoring visits and
audits
Safety monitoring and reporting
Source documentation
Data entry and reconciliation
Electronic medication orders (Beacon)
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Appendix C

Note. IHI Model for Improvement. Reprinted with permission from John Wiley and Sons. Copied from the Institute
for Healthcare Improvement. Science of improvement: Testing changes. IHI n.d.
http://www.ihi.org/resources/Pages/HowtoImprove/ScienceofImprovementTestingChanges.aspx
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Appendix D
OPAL Pyramid Scale

Note. The Ontario Protocol Assessment Level (OPAL) pyramid scale. Copied from “Ontario Protocol Assessment
Level: Clinical Trial Complexity Rating Tool for Workload Planning in Oncology Clinical Trials”, by Smuck, B. et
al., 2011, Journal of Oncology Practice, 7(2), p.82. Copyright 2011 by American Society of Clinical Oncology.
Reprinted with permission.
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Appendix E
Job Stress Questionnaire Dimension 1
Job Requirements:
Dimension 1

Rarely

Occasionally

Sometimes

Fairly
Often

How often does your
job require you to
work very fast?

1

4

8

4

How often does your
job require you to
work very hard?

1

1

5

7

How often does your
job leave you with
little time to get
things done?

3

3

6

4

How of often is there
a great deal to be
done?

1

1

7

7

1

3

10

3

2

6

7

How often is there
marked increase in
the workload?
How often is there
marked increase in
the amount of
concentration
required on your
job?

Very
Often

2

1

1

How often is there a
marked increase in
how fast you have to
think?

1

4

6

5

How often does your
job let you use the
skills and knowledge
you learned in
school?

3

3

3

5

2

How often are you
given a chance to do
the things you do the
best?

2

1

4

7

2

3

4

8

1

How often can you
use the skills from
your previous
experience and
training?
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Appendix F
Job Stress Questionnaire Dimension 2
Workload and
Responsibility:
Dimension 2
How much
slowdown in the
workload do
you experience?

Hardly Any

A Little

Some

1

8

7

1

How much time
do you have to
think and
contemplate?

A Lot

A Great Deal

1

11

3

How much
workload do
you have?

6

10

What quantity
of work do
others expect
you to do?

9

7

6

8

6

9

How much time
do you have to
do all your
work?

2

How many
projects,
assignments, or
tasks do you
have?
How many lulls
between heavy
workload
periods do you
have?
How much
responsibility
do you have for
the future of
others?
How much
responsibility
do you have for
the job security
of others?

1

1

5

9

1

4

2

8

1

1

8

1

5

1

1

How much
responsibility
do you have for
the morale of
others?

4

1

7

3

1

How much
responsibility
do you have for
the welfare and
lives of others?

3

3

8

2
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Appendix G
Job Stress Questionnaire Dimension 3
Mental
Demands:
Dimension 3

Slightly
Disagree

Strongly
Disagree

Strongly Agree

Slightly Agree

My job
requires a
great deal of
concentration.

11

4

1

My job
requires me to
remember
many different
things.

12

2

1

I must keep my
mind on my
work at all
times.

6

10

I can take it
easy and still
get my work
done.

2

9

5

I can let my
mind wander
and still do the
work.

1

9

5
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Appendix H
Job Satisfaction Dimension 4
Job Satisfaction: Dimension 4
Knowing what you know now, if
you had to decide all over again
whether to take the type of job you
now have, what would you decide?

I would decide without hesitation to take the
same job.
I would have some second thoughts.
I would decide definitely not to take this type of
job.

If you were free right now to go into
any type of job you wanted, what
would your choice be?

I would take the same job.
I would take a different job.
I would not want to work.

11
5

If a friend of yours told you he/she
was interested in working in a job
like yours, what would you tell
him/her?

I would strongly recommend it.
I would have doubts about recommending it.

15

I would advise against it.

1

All in all, how satisfied would you
say you are with your job?

I am very satisfied.
I am somewhat satisfied.
I am not too satisfied.

8
8

14
2

